Spero Therapeutics (SPRO) Return on Sales Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 4.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.00 |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | -26.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.00 |
| Dec 31, 2025 | -3.00 |
| Sep 30, 2025 | 271.00 |
| Jun 30, 2025 | 3.00 |
| Mar 31, 2025 | -1.00 |
| Dec 31, 2024 | -2.00 |
| Sep 30, 2024 | -258.00 |
| Jun 30, 2024 | 1.00 |
| Mar 31, 2024 | 58.00 |
| Dec 31, 2023 | -1.00 |
| Sep 30, 2023 | -9.00 |
| Jun 30, 2023 | 9.00 |
| Mar 31, 2023 | -45.00 |
| Dec 31, 2022 | 3.00 |
| Sep 30, 2022 | 26.00 |
| Jun 30, 2022 | -4.00 |
| Mar 31, 2022 | -12.00 |
| Dec 31, 2021 | 21.00 |
| Sep 30, 2021 | 468.00 |
| Jun 30, 2021 | 2.00 |
| Mar 31, 2021 | 11.00 |
| Dec 31, 2020 | 14.00 |
| Sep 30, 2020 | -496.00 |
| Jun 30, 2020 | 188.00 |
| Mar 31, 2020 | -13.00 |
| Dec 31, 2019 | -30.00 |
| Sep 30, 2019 | 12.00 |
| Jun 30, 2019 | -177.00 |
| Mar 31, 2019 | 23.00 |
| Dec 31, 2018 | 8.00 |
| Sep 30, 2018 | 1.00 |
| Jun 30, 2018 | 19.00 |
| Mar 31, 2018 | 30.00 |
| Dec 31, 2017 | -149.00 |
| Sep 30, 2017 | 63.00 |